C.F.R. homeSearch C.F.R.
C.F.R.Title 9Chapter I—Animal and Plant Health Inspection Service, Department of AgricultureSubchapter E—Viruses, Serums, Toxins, And Analogous Products; Organisms and VectorsPart 102—Licenses for Biological Products

9 C.F.R. § 102.3 (2026)

License applications

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 1988–1999 6citing cases

(a) U.S. Veterinary Biologics Establishment License. (1) The operator of each establishment of the kind specified in § 102.2 shall make written application to the Administrator for a license. Blank forms of application will be furnished upon request to Animal and Plant Health Inspection Service.

(2) When a person conducts more than one establishment, a separate application shall be made for each establishment.

(3) Whenever subsidiaries are to operate in an establishment for which license application is made, the applicant shall apply for permission for such subsidiaries to operate in the establishment and furnish therewith a complete statement regarding the relationship between the applicant and the subsidiaries.

(4) Facilities documents, prepared as prescribed in part 108 of this subchapter, shall accompany the application for license unless previously filed with Animal and Plant Health Inspection Service.

(5) Each application for a U.S. Veterinary Biologics Establishment License shall be accompanied by an application for one or more U.S. Veterinary Biological Product Licenses and the supporting documents required by paragraph (b)(2) of this section.

(6) A new application shall be made when a change of ownership, operation, or location of an establishment occurs; or prior to the expiration of a U.S. Veterinary Biologics Establishment License issued for an interim period of time.

(b) U.S. Veterinary Biological Product License. (1) The licensee of each establishment or applicant for an establishment license shall make written application to the Administrator for a U.S. Veterinary Biological Product License for each biological product to be prepared in the licensed establishment.

(2) Each application for a U.S. Veterinary Biological Product License shall be supported by:

(i) At least two copies of an Outline of Production prepared in accordance with §§ 114.8 and 114.9 of this subchapter; and

(ii) At least three copies of test reports and research data sufficient to establish purity, safety, potency, and efficacy of the product; and

(iii) Legends prepared as prescribed in § 108.5 of this subchapter designating which facilities are to be used in the preparation of each fraction; and

(iv) Labels in finished form or sketches prepared as prescribed in § 112.5 of this subchapter, together with information regarding all claims to be made on labels and in advertising matter to be used in connection with or related to the biological product.

(Approved by the Office of Management and Budget under control number 0579-0013) [39 FR 37763, Oct. 24, 1974, as amended at 48 FR 57472, Dec. 30, 1983; 49 FR 21043, May 18, 1984; 50 FR 50763, Dec. 12, 1985; 56 FR 66783, Dec. 26, 1991; 75 FR 20772, Apr. 21, 2010]
The 6 cases that cite 9 C.F.R. § 102.3 most heavily, weighted by court and treatment. RelevanceNewestTreatment
cites § 102.3 2×cited by 28 cases
Where it cites § 102.3
“See 9 C.F.R. §§ 102.3 (b)(2)(i), 114.8-.9. The regulations detail ingredient requirements, such as the types of cell lines that must be used to produce biologies.”
Later courts cite it for
“an intent to preempt may ... be implied, for example, when federal and state laws directly conflict, when state law stands as an obstacle to accomplishing the purposes of federal law, or when federal law is so pervasive that it reflects an intent to occupy a regulatory field.” · 3 citing courts
2
GREENSymens v. Smithkline Beecham Corp., 19 F. Supp. 2d 1062 (D.S.D. 1997).
cites § 102.3 1×cited by 9 cases
Where it cites § 102.3
“9 C.F.R. § 102.3 (a). Each license application must include “labels in finished form together with information regarding all claims to be made on labels and in advertising matter to be used in connection with or related to the biological product.”
3
GREENFound. on Econ. Trends v. Lyng, 680 F. Supp. 10 (D.D.C. 1988).
cites § 102.3 1×cited by 5 cases
Where it cites § 102.3
“9 C.F.R. § 102.3 (b)(2)(H) (1987). Vaccines and other veterinary biological products that are prepared using biotechnological or “genetic engineering” procedures must comply with these licensing regulations.”
4
GREENSjovall v. Smithkline Beecham Corp., 16 F. Supp. 2d 1112 (D.S.D. 1997).
cites § 102.3 1×cited by 1 case
Where it cites § 102.3
“9 C.F.R. § 102.3 (a). Each license application must include “labels in finished form together with information regarding all claims to be made on labels and in advertising matter to be used in connection with or related to the biological product.”
5
NO FLAGSymens v. Smithkline Beecham Corp., 593 F. Supp. 2d 1075 (D.S.D. 1999).
cites § 102.3 2×cited by 0 cases
Where it cites § 102.3
“See 9 C.F.R. § 102.3 (b)(2)(ii). Therefore, by granting the license to manufacture the vaccine, APHIS would logically have determined that the vaccine was safe and effective.”
6
NO FLAGRichard Symens v. Smithkline Beecham, No. 98-1055 (8th Cir. Aug. 27, 1998).
cites § 102.3 2×cited by 0 cases
Where it cites § 102.3
“See 9 C.F.R. §§ 102.3 (b)(2)(i), 114.8-.9. The regulations detail ingredient requirements, such as the types of cell lines that must be used to produce biologics.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
198819931999

One bar per year. Tallest: 2 cases in 1997. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
D.S.D.38th Cir.2D.D.C.1
By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com